Leprosy

Approved for this indication (2)

• dapsone
• sulfoxone

Phase 4 trials (2)

• clofazimine
• rifampin

Phase 3 trials (5)

• amitriptyline
• prednisone
• cyclosporine
• tramadol
• bedaquiline

Phase 2 trials (6)

• metformin
• cc-11050
• coconut oil
• gla-se
• Tuberculin, Purified Protein Derivative
• lep-f1

Phase 1 trials (3)

• mlcwa
• mlsa-lam
• lepvax

Other trials (2)

• montelukast
• jinfukang koufuye

Organization Involved with Phase 4 Indications (23)

• National Center for Research Resources (NCRR)
• United States Army
• Conselho Nacional de Desenvolvimento Científico e Tecnológico
• Liaocheng People's Hospital
• Shandong Provincial Hospital
• Shandong Provincial Institute of Dermatology and Venereology
• Texas Tech University
• University of Brasilia
• Leonard Wood Memorial
• Shandong Province Qianfoshan Hospital
• Jinan University
• Qingdao Center Medical Group
• Dongying People's Hospital, Shandong
• Shandong Jining No. 1 People's Hospital
• Dezhou People's Hospital,Shandong
• Linyi City Dermatology Hospital Prevention and Treatment
• Jining City Dermatology Hospital Prevention and Treatment
• Weifang City Dermatology Hospital Prevention and Treatment
• Laiwu City Dermatology Hospital Prevention and Treatment
• Rizhao City Dermatology Hospital Prevention and Treatment
• Government of Brazil
• Instituto de Dermatologia Dona Libania, Fortaleza, Brazil
• People's Liberation Army of China

Organization Involved with Phase 3 Indications (13)

• Cristália Produtos Químicos Farmacêuticos Ltda.
• Armauer Hansen Research Institute, Ethiopia
• University of London
• Institute of Tropical Medicine, Belgium
• Leiden University
• Damien Foundation Bangladesh
• University of Sao Paulo
• Instituto de Medicina Integral Professor Fernando Figueira
• Alert Hospital, Ethiopia
• L'Institut National de la Santé et de la Recherche Médicale
• Fondation Raoul Follereau
• Centre d’Infectiologie Charles Mérieux
• Genoscreen

Organization Involved with Phase 2 Indications (6)

• Immune Design
• National Institute of Allergy and Infectious Diseases (NIAID)
• Philippine Dermatological Society
• Johnson and Johnson
• Oswaldo Cruz Foundation
• The Leprosy Mission Nepal

Organization Involved with Phase 1 Indications (1)

• American Leprosy Missions

Organization Involved with Other Experimental Indications (4)

• Kaiser Permanente
• Rio de Janeiro State University
• The Leprosy Mission Bangladesh
• Health Resources and Services Administration (HRSA)